PTGS2 and benign prostatic hyperplasia: Non-steroidal anti-inflammatory treatments (NSAIDs) and cyclooxygenase-2 (COX-2) inhibitors have shown positive effects on the lower urinary tract symptoms (LUTS) attributable to BPH [9,10].